Израел -
Хебрејски -
Ministry of Health
פלויקס 75 מג
sanofi israel ltd - clopidogrel as hydrogen sulfate - טבליות מצופות פילם - clopidogrel as hydrogen sulfate 75 mg - clopidogrel - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid
Израел -
Хебрејски -
Ministry of Health
פלויקס 300 מ"ג
sanofi - aventis israel ltd - clopidogrel as hydrogen sulfate 300 mg - film coated tablets - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid
Израел -
Хебрејски -
Ministry of Health
פניומו 23
medici medical ltd, israel - streptococcus pneumoniae - תמיסה להזרקה - streptococcus pneumoniae 25 mcg / 0.5 ml - pneumococcus, purified polysaccharides antigen - pneumococcus, purified polysaccharides antigen - prevention of pneumococcal infections, particularly of the respiratory type, in patients presenting an increased risk over the age of 2 years.
Израел -
Хебрејски -
Ministry of Health
אופטיקרום טפות עיניים
sanofi - aventis israel ltd - cromoglicic acid as sodium 2 %w/v - eye drops - cromoglicic acid - preventive treatment for all types of allergic conjunctivitis.
Израел -
Хебрејски -
Ministry of Health
קרומופטיק
vitamed pharmaceutical industries ltd - cromoglicic acid sodium - טיפות עיניים - cromoglicic acid sodium 2 %w/v - cromoglicic acid - cromoglicic acid - preventative treatment of all forms of allergic conjunctivitis.
Израел -
Хебрејски -
Ministry of Health
קיטריל
roche pharmaceuticals (israel) ltd - granisetron as hydrochloride 1 mg - film coated tablets - granisetron - prevention of nausea and vomliting induced by cytostatic therapy.
Израел -
Хебрејски -
Ministry of Health
סטרון 1 מג
padagis israel agencies ltd, israel - granisetron as hydrochloride - טבליה - granisetron as hydrochloride 1 mg - granisetron - granisetron - prevention of nausea and vomiting induced by cytostatic therapy.